Rapid advancements in materials science and nanotechnology, intertwined with oncology,
have positioned photothermal therapy (PTT) as a promising noninvasive treatment strategy …

Simple Summary Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)
plays an important role in apoptosis and tumor immunosurveillance. Because TRAIL …

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) demonstrates unique
characteristics in anticancer therapies as it selectively induces apoptosis in cancer cells …

Triple-negative breast cancer (TNBC) lacks estrogen receptor, progesterone receptor, and
human epidermal growth factor receptor 2 expressions, making targeted therapies …

Small extracellular vesicles (sEVs) are nanosized vesicles. Death receptor 5 (DR5)
mediates extrinsic apoptosis. We engineer DR5 agonistic single-chain variable fragment …

Background Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor
outcomes, especially in older AML patients. Tumor necrosis factor-related apoptosis …

Lung cancer is a deadly disease, causing nearly 20% of all cancer deaths globally. A key
factor in lung cancer's development and resistance to treatment is hypoxia, a condition …

Colorectal cancer is one of the most common cancers worldwide, affecting the colon and
rectum. A major problem in the treatment of colorectal cancer is acquired chemoresistance …

Abstract Introduction: Osteoprotegerin (OPG), encoded by the TNFRSF11B gene, is linked to
the development of breast cancer via several pathways, including interactions with the …

The aim of this review is to provide experimental evidence for the programmed-death activity
of Ashwagandha (Withania somnifera) in the anti-cancer therapy of breast cancer. The …